Lack of effect of nizatidine on hepatic drug metabolism in man.
Open Access
- 1 December 1985
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 20 (6), 710-713
- https://doi.org/10.1111/j.1365-2125.1985.tb05136.x
Abstract
The effect of nizatidine, a new H2-receptor antagonist, on the hepatic metabolism of three probe drugs was studied in normal volunteers. The drugs studied were chlordiazepoxide and theophylline which are metabolized in part by N-demethylation by the hepatic microsomal cytochrome P-450 system and lorazepam which is conjugated to lorazepam glucuronide. A 7 day course of nizatidine did not interfere with the disposition of any of these therapeutic agents in man.This publication has 21 references indexed in Scilit:
- Nizatidine, a new histamine H2-receptor antagonist, and hepatic oxidative drug metabolism in the rat: A comparison with structurally related compoundsToxicology and Applied Pharmacology, 1985
- Ranitidine: A New H2-Receptor AntagonistNew England Journal of Medicine, 1983
- Ranitidine or CimetidineAnnals of Internal Medicine, 1983
- A nonlinear regression program for small computersAnalytical Biochemistry, 1981
- Cimetidine Impairs Elimination of Chlordiazepoxide (Librium) in ManAnnals of Internal Medicine, 1980
- High-pressure Liquid Chromatographic Determination of Chlordiazepoxide and its major Metabolites in Biological FluidsJournal of Pharmaceutical Sciences, 1979
- Plasma Binding of Benzodiazepines in HumansJournal of Pharmaceutical Sciences, 1979
- Effects of aging and liver disease on disposition of lorazepamClinical Pharmacology & Therapeutics, 1978
- Effects of Caffeine on Plasma Renin Activity, Catecholamines and Blood PressureNew England Journal of Medicine, 1978
- A physiological approach to hepatic drug clearanceClinical Pharmacology & Therapeutics, 1975